Steigerwald Gordon & Koch’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Hold
2,796
0.33% 49
2026
Q1
$2.57M Sell
2,796
-18
-0.6% -$18.2K 0.26% 56
2025
Q4
$3.02M Buy
2,814
+44
+2% +$42.1K 0.29% 55
2025
Q3
$2.11M Sell
2,770
-178
-6% -$132K 0.2% 59
2025
Q2
$2.3M Sell
2,948
-145
-5% -$113K 0.24% 52
2025
Q1
$2.55M Sell
3,093
-2
-0.1% -$1.66K 0.29% 50
2024
Q4
$2.39M Sell
3,095
-37
-1% -$30.6K 0.27% 50
2024
Q3
$2.78M Buy
3,132
+13
+0.4% +$11.7K 0.3% 48
2024
Q2
$2.82M Sell
3,119
-53
-2% -$42.4K 0.34% 48
2024
Q1
$2.47M Sell
3,172
-255
-7% -$181K 0.31% 48
2023
Q4
$2M Buy
3,427
+175
+5% +$102K 0.27% 48
2023
Q3
$1.75M Sell
3,252
-50
-2% -$25.8K 0.27% 47
2023
Q2
$1.55M Buy
3,302
+1
+0% +$419 0.23% 46
2023
Q1
$1.13M Sell
3,301
-255
-7% -$86K 0.17% 51
2022
Q4
$1.3M Sell
3,556
-167
-4% -$59.2K 0.21% 50
2022
Q3
$1.2M Sell
3,723
-46
-1% -$14.6K 0.22% 50
2022
Q2
$1.22M Buy
3,769
+603
+19% +$181K 0.21% 52
2022
Q1
$907K Sell
3,166
-613
-16% -$158K 0.14% 61
2021
Q4
$1.04M Hold
3,779
0.16% 60
2021
Q3
$873K Sell
3,779
-70
-2% -$17.3K 0.14% 59
2021
Q2
$884K Hold
3,849
0.15% 58
2021
Q1
$719K Sell
3,849
-278
-7% -$54.4K 0.13% 62
2020
Q4
$697K Buy
4,127
+48
+1% +$7.17K 0.14% 60
2020
Q3
$604K Sell
4,079
-4
-0.1% -$619 0.14% 58
2020
Q2
$670K Hold
4,083
0.18% 57
2020
Q1
$566K Buy
4,083
+778
+24% +$107K 0.19% 57
2019
Q4
$434K Buy
3,305
+1,255
+61% +$145K 0.1% 67
2019
Q3
$229K Sell
2,050
-24
-1% -$2.67K 0.06% 77
2019
Q2
$230K Sell
2,074
-500
-19% -$58.9K 0.06% 76
2019
Q1
$334K Sell
2,574
-426
-14% -$51.8K 0.09% 64
2018
Q4
$347K Hold
3,000
0.1% 63
2018
Q3
$322K Hold
3,000
0.08% 72
2018
Q2
$256K Sell
3,000
-300
-9% -$24.6K 0.07% 76
2018
Q1
$255K Sell
3,300
-400
-11% -$32.2K 0.07% 73
2017
Q4
$313K Buy
+3,700
New +$315K 0.09% 65

Other funds holding LLY

Steigerwald Gordon & Koch's LLY Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Eli Lilly (LLY) position steady in Q2 2026 at 2,796 shares worth $3.35M. The position accounts for 0.33% of the portfolio, ranked #49.

Steigerwald Gordon & Koch first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steigerwald Gordon & Koch held 2,796 shares of Eli Lilly worth $3.35M as of Q2 2026.
  • Steigerwald Gordon & Koch left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.33% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #49 holding.
  • Steigerwald Gordon & Koch first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.